Wave Life Sciences financials at a glance

+ Portfolio

The revenue of Wave Life Sciences is reported as 0.11331 billion Dollars in the fiscal year 2023. The earnings were -0.54 Dollars per share in 2023, which was 73.66 higher than 2022. And about -0.02055 billion Dollars are reported as free cash flow in the financials of Wave Life Sciences 2023. No dividends were paid to the shareholders of the Wave Life Sciences stock NasdaqGM:WVE in the financial year 2023.

$113.31M

Revenue

$-0.54

Earnings Per Share

-14.74%

Gross Margin %

$-26.64M

Free Cash Flow

Revenue

113.31

Earnings Per Share

-0.54

Gross Margin %

-14.74

Free Cash Flow

-26.64

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015
Rev.	Revenue	N/A	$113.31M	$3.65M	$40.96M	$20.08M	$15.98M	$14.41M	$3.70M	$1.49M	$0.15M
GM %	Gross Margin %	-48.57%	-14.74%	0.00%	-,197.52%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	-,108.64%	-60.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-0.83	$-0.54	$-2.05	$-2.36	$-3.82	$-5.72	$-5.06	$-3.85	$-2.43	$-1.83
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	122.28M	98.1M	60.84M	49M	34.54M	34.19M	27.99M	23.54M	21.55M
OCF	Operating Cash Flow	N/A	$-19.43M	$-,127.78M	$-88.99M	$-,115.98M	$-,187.03M	$-22.86M	$-83.67M	$-31.87M	$-12.53M
FCF	Free Cash Flow	N/A	$-26.64M	$-,129.14M	$-89.55M	$-,117.37M	$-,192.15M	$-32.80M	$-,102.56M	$-37.44M	$-14.39M
FCFS	Free Cash Flow Per Share	$-0.20	$-0.19	$-1.64	$-1.73	$-2.99	$-5.67	$-1.13	$-3.87	$-1.64	$-1.37

Wave Life Sciences financials at a glance

Financials

Discover